JIANGSU BIOPERFECTUS TECHNOLOGIES CO., LTD. Jiangsu Bioperfectus Technologies Co., Ltd. Stock
Equities
688399
CNE1000055B2
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.99 CNY | -1.35% |
|
+0.53% | +35.61% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 5.53B 765M | Sales 2023 | 403M 55.71M | Capitalization | 3.2B 442M |
|---|---|---|---|---|---|
| Net income 2022 | 1.83B 253M | Net income 2023 | -374M -51.68M | EV / Sales 2022 | 0.44 x |
| Net cash position 2022 | 2.7B 374M | Net cash position 2023 | 2.29B 317M | EV / Sales 2023 | 2.25 x |
| P/E ratio 2022 |
2.81
x | P/E ratio 2023 |
-8.55
x | Employees | 1,082 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.65% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.35% | ||
| 1 week | +0.53% | ||
| Current month | +0.75% | ||
| 1 month | +9.13% | ||
| 3 months | +39.13% | ||
| 6 months | +35.19% | ||
| Current year | +35.61% |
1 week
73.35
75.98
1 month
65.0075.98
Current year
49.0275.98
1 year
46.5275.98
3 years
46.52219.60
5 years
46.52476.76
10 years
46.52476.76
| Managers | Title | Age | Since |
|---|---|---|---|
Guo Qiang Wang
CEO | Chief Executive Officer | 54 | 10-03-31 |
Yuan Yuan Meng
DFI | Director of Finance/CFO | 40 | 23-06-29 |
Zhong Hua Liu
CTO | Chief Tech/Sci/R&D Officer | 55 | 10-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shao Min Shao
BRD | Director/Board Member | 60 | 17-07-31 |
Yong Sheng Fang
BRD | Director/Board Member | 70 | 11-02-28 |
Guo Qiang Wang
CEO | Chief Executive Officer | 54 | 10-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.06% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 73.99 | -1.35% | 622,268 |
| 24-05-10 | 75 | -0.50% | 542,867 |
| 24-05-09 | 75.38 | +0.43% | 271,589 |
| 24-05-08 | 75.06 | +0.27% | 448,939 |
| 24-05-07 | 74.86 | +1.71% | 542,153 |
End-of-day quote Shanghai S.E., May 12, 2024
More quotes
Jiangsu Bioperfectus Technologies Co Ltd is a China-based company mainly engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The Company mainly conducts its businesses in domestic and overseas markets.
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +35.61% | 608M | |
| -3.58% | 12.64B | |
| -1.48% | 8.46B | |
| +8.70% | 5.66B | |
| +25.61% | 5.27B | |
| -4.58% | 4.49B | |
| -51.80% | 3.11B | |
| +16.25% | 2.87B | |
| +30.25% | 2.31B | |
| -4.08% | 1.89B |
- Stock Market
- Equities
- 688399 Stock
